Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk
- 1 March 1996
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 24 (3), 392-397
- https://doi.org/10.1097/00003246-199603000-00006
Abstract
The aims of this study were: a) to evaluate plasma concentrations of cytokines and their soluble receptors, as well as antioxidant substances in patients at high risk of developing multiple organ failure; b) to investigate early change: and c) to examine the possible prognostic value of these elements. Prospective analysis. Surgical intensive care unit (ICU) of a university hospital. sixteen patients at risk for multiple organ failure. Ten patients developed multiple organ failure and five of them died. Whereas tumor necrosis factor-alpha (TNF-alpha) plasma concentrations were only borderline higher in patients developing multiple organ failure, TNF-soluble receptors 55 and 75 were significantly increased during all ICU days compared with patients not going into organ failure. Interleukin-6 plasma concentrations were higher in patients developing multiple organ failure during the first 2 days after ICU admission. The antioxidant vitamin C was significantly decreased in patients going into multiple organ failure during all ICU days. Other biochemical markers of antioxidant activity, such as vitamin E, copper, and zinc plasma concentrations, did not differ between the two groups. Our data suggest that there is a marked increase in anti-TNF activity and a decrease of antioxidant defense in patients at risk of developing multiple organ failure. The predictive value of plasma concentrations of circulating TNF-soluble receptors and vitamin C in this type of patient needs further evaluation.This publication has 30 references indexed in Scilit:
- Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- Neutrophil function and lipid peroxidation in a rat model of multiple organ failureJournal of Surgical Research, 1989
- Plasma tumor necrosis factor and mortality in critically ill septic patientsCritical Care Medicine, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraThe New England Journal of Medicine, 1988
- A human inhibitor of tumor necrosis factor alpha.The Journal of Experimental Medicine, 1988
- Multiple-Organ Failure and Sepsis Without BacteriaArchives of Surgery, 1986
- Multiple-Organ FailureArchives of Surgery, 1985
- Multiple Systems Organ FailureThe Journal of Trauma and Acute Care Surgery, 1981